New Product Growth Drivers In Cold/Allergy/Sinus: Nothing To Sneeze At – IRI
This article was originally published in The Tan Sheet
Executive Summary
Sales of Mucinex DM and Sudafed PE helped drive OTC cold/allergy/sinus category sales up 11.4% to $2.7 bil. in 2005, according to Information Resources, Inc
You may also be interested in...
Adams Brings Mucinex To Pediatric Market; Humibid Launch Slated For March
Adams Respiratory Therapeutics will launch a line of cough/cold products for children under the Mucinex brand name by the end of 2006
Energizer Grows Personal Care With Acquisition Of Leading Sun-Care Brands
Energizer Holdings will gain Banana Boat and Hawaiian Tropic - the No. 2- and No. 4-selling sun- care brands, respectively - through its $1.9 billion purchase of Playtex Products, the companies announce July 12
Physicians Formula Continues To Solve Real, Perceived Problems Into 2008
Physicians Formula, which has found success distinguishing itself as a "problem/solution brand" since its inception, plans to remain competitive in 2008 and beyond with a three-pronged plan of attack, according to CEO Ingrid Jackel